Monitoring prostate cancer offers the same survival chance as surgery or radiotherapy over 10 years, but treatment reduces risk of cancer progression

Largest UK trial of treatment for prostate cancer publishes first results Active monitoring is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind, funded by the National Institute for Health Research (NIHR). Results published in New England Journal of Medicine today, show that all...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news